Manage Your Liver
Q:

‘ALT Focused Therapy’: A new approach to manage chronic liver diseases

‘ALT Focused Therapy’: A new approach to manage chronic liver diseases
A:

The number of deaths caused by liver cancer is constantly increasing; in 2012, liver cancer has caused more deaths than any other cancers globally. The prevalence and severity liver disease is obvious. To liver disease patients, nothing is more worrying than chronic inflammation and the possibility of developing more serious liver diseases.

 

To change the situation and treat liver disease more effectively, other than developing new medicine, reinforcing protection work and maintaining a healthy lifestyle, we should also understand the weaknesses of the current treatment and make adjustments accordingly. Let’s look at the illustration below:

 

 

We can see that the treatment process now aims to eliminate the cause of liver damage first (e.g. Hepatitis virus, fat, alcohol, etc.). Then, the liver’s self-repair ability allows liver cells to recover  normal liver function to resume. The biggest problem and weakness of this approach is the long period of liver cell injury (the red bar). In addition, the success rate of most drugs is low while the cost is high; not to mention the long treatment time and severe side effects. In other words, the current treatment approach lacks focus on the recovery process. Chronic liver injury  causes liver fibrosis, cirrhosis and increases the risk of liver cancer greatly.

 

In view of this, chronic liver disease patients should focus on enhancing liver cell recovery and shortening the time with liver damage. We therefore suggest ‘ALT Focused Therapy’:

 

 

The major advantage of ‘ALT Focused Therapy’ is that the most urgent and dangerous problem is tackled first. By first stopping long term injury to liver cells, liver fibrosis and cirrhosis can be prevented, and the chance of liver cancer can be reduced. After liver function is improved, patients can then carry out drug treatment to eliminate the harmful substances in their body gradually. When compared with the current approach, ‘ALT Focused Therapy’ can help patients greatly reduce the time with liver injury (the red bar is shortened significantly).  

 

To carry out ALT Focused Therapy, YHK is a safe and effective formula that can help liver cell recovery. Clinical Research shows that YHK can effectively normalise ALT level and improve liver health quickly (within 10-30 days). It is an ideal options for liver patients who wish to quickly repair their liver cells and improve liver function.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
“It isn't fat but rather fibrosis that drives disease progression in people with advanced non-alcoholic steatohepatitis (NASH).”   NASH is one of the most prevalent liver diseases nowadays. NASH is related to non-alcoholic fatty liver disease (NAFLD) which is characterized by the buildup of fat in the liver. Although it is normal to have some fat in the liver, some people might develop inflammation because of this fat accumulation, this is cal
Hit Questions
A:
YHK has significant effect in stopping liver inflammation; it can enhance the recovery of liver health and protect liver cells. Those who have experienced YHK often have these questions in mind: Why is YHK so different from other liver medicines and supplements? Why is it possible to have such unprecedented effects? The answer seems magical, but in fact, it is not complicated - Because YHK possesses a perfect balance.   To explain this, we must first point out that YH
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
“It isn't fat but rather fibrosis that drives disease progression in people with advanced non-alcoholic steatohepatitis (NASH).”   NASH is one of the most prevalent liver diseases nowadays. NASH is related to non-alcoholic fatty liver disease (NAFLD) which is characterized by the buildup of fat in the liver. Although it is normal to have some fat in the liver, some people might develop inflammation because of this fat accumulation, this is cal
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us